Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways
Open Access
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (27), 24571-24578
- https://doi.org/10.1074/jbc.m202561200
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to ActivinJournal of Biological Chemistry, 2001
- Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancerThe Journal of Pathology, 2000
- Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase ActivityJournal of Biological Chemistry, 2000
- Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-β activated cellsCytokine & Growth Factor Reviews, 1999
- Effects of transforming growth factor β1 on cell growth and parathyroid hormone-related protein in Walker 256 tumor cellsLife Sciences, 1999
- A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF‐β signalsFEBS Letters, 1998
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Transforming growth factor β stimulation of parathyroid hormone-related protein (PTHrP): A paracrine regulator?Molecular and Cellular Endocrinology, 1993